Delivery Order SPE2DR25D1104-SPE2DR26FK221
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Durolane 60 mg/3 ml syringes with a contract value of $12,633.03 and a completion date of October 31, 2025. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,375.69 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on May 6, 2025, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a viscosupplement injection used for osteoarthritis treatment, reflecting the Defense Logistics Agency Medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,781.85 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on May 5, 2025, with an ultimate completion date of May 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable treatment commonly used for joint pain management,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,232.37 for Durolane 60 mg/3 ml syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-use procurement of the injectable hyaluronic acid product, which is commonly used for osteoarthritis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $12,697.01. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $4,949.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for DUROLANE 60MG/3ML, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This firm fixed-price delivery order, valued at $9,790.21, was competitively awarded without set-aside designation and carries an ultimate completion date of October 22, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,347.52 by the Defense Logistics Agency on August 1, 2025, for Durolane 60 mg/3 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance is scheduled for completion by August 4, 2025, with work to be performed at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,618.97 for Durolane 60 mg/3 ml syringes on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The place of performance is...